Literature DB >> 9536876

Intrascleral dissemination of infectious scleritis following pterygium excision.

C H Hsiao1, J J Chen, S C Huang, H K Ma, P Y Chen, R J Tsai.   

Abstract

AIMS: To assess the clinical pictures, possible pathogenesis, management, and therapy of patients with infectious scleritis associated with multifocal scleral abscesses following pterygium excision.
METHODS: The records of patients with infectious scleritis after pterygium excision who developed multifocal scleral abscesses presenting from 1988 to the end of 1995 were reviewed. Early culture of abscesses was performed, and topical, systemic antimicrobials, or both were given to all patients. Fourteen eyes were operated on in addition to antimicrobial treatment.
RESULTS: The initial culture reports of scleral ulcers identified Pseudomonas species in 12 of these 18 patients, Aspergillus in one, Mycobacterium fortuitum in one, and mixed organisms in four. Subsequent abscess cultures were taken from 15 of the infected eyes, and revealed the same organism as the initial culture in 12. Associated complications included four serous retinal detachments, three choroidal detachments, two double detachments, five complicated cataracts, and four recurrences of the initial infection. Four eyes required eventual enucleation and 11 eyes regained useful vision.
CONCLUSIONS: With subsequent abscess cultures proving to be the same organism as found in the initial ulcer, the abscess formation appears to represent intrascleral dissemination. Early diagnosis and appropriate, prolonged topical plus systemic antimicrobial treatment are essential to halt the progression of such severe infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536876      PMCID: PMC1722356          DOI: 10.1136/bjo.82.1.29

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  RECURRENCE OF A CORNEAL PSEUDOMONAS INFECTION AFTER TOPICAL STEROID THERAPY: REPORT OF A CASE.

Authors:  T HARBIN
Journal:  Am J Ophthalmol       Date:  1964-10       Impact factor: 5.258

2.  Repair of a giant scleral ulcer with a scleral graft and tissue glue.

Authors:  C P Lin; Y H Wu; M T Chen; W L Huang
Journal:  Am J Ophthalmol       Date:  1991-02-15       Impact factor: 5.258

3.  Bacterial corneoscleritis complicating pterygium excision.

Authors:  P L Farrell; R E Smith
Journal:  Am J Ophthalmol       Date:  1989-05-15       Impact factor: 5.258

4.  Pseudomonas corneoscleritis.

Authors:  E Alfonso; K R Kenyon; L D Ormerod; R Stevens; M D Wagoner; D M Albert
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

5.  Late complications of pterygium treatment.

Authors:  K H Tarr; I J Constable
Journal:  Br J Ophthalmol       Date:  1980-07       Impact factor: 4.638

6.  Pseudomonas corneoscleral ulcers.

Authors:  I M Raber; P R Laibson; G H Kurz; V B Bernardino
Journal:  Am J Ophthalmol       Date:  1981-09       Impact factor: 5.258

7.  Multiple scleral abscesses with recurrent bacterial endophthalmitis eight months following cataract surgery.

Authors:  J Ram; A Sharma; A Gupta
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-10

8.  Scleritis and Streptococcus pneumoniae.

Authors:  A J Altman; E J Cohen; S T Berger; B J Mondino
Journal:  Cornea       Date:  1991-07       Impact factor: 2.651

9.  Aspergillus panophthalmitis complicating treatment of pterygium.

Authors:  C E Margo; F M Polack; C I Hood; C I Mood
Journal:  Cornea       Date:  1988       Impact factor: 2.651

10.  Scleral abscesses and ectasia caused by Pseudomonas aeruginosa.

Authors:  D K Berler; M G Alper
Journal:  Ann Ophthalmol       Date:  1982-07
View more
  29 in total

1.  Pseudomonas scleral abscess following pars plana vitrectomy.

Authors:  Wataru Saito; Takanori Sakaguchi; Naoki Furudate; Yasufumi Amino; Shigeaki Ohno
Journal:  Jpn J Ophthalmol       Date:  2006 Nov-Dec       Impact factor: 2.447

2.  Epidemiology and recurrence rate of pterygium post excision in Ghanaians.

Authors:  V A Essuman; C T Ntim-Amponsah; G K Vemuganti; T A Ndanu
Journal:  Ghana Med J       Date:  2014-03

3.  Infectious Pseudomonas and Bipolaris scleritis following history of pterygium surgery.

Authors:  Ashkan M Abbey; Nisha V Shah; Richard K Forster; Leejee H Suh
Journal:  Indian J Ophthalmol       Date:  2016-09       Impact factor: 1.848

4.  Fungal scleral keratitis caused by Phomopsis phoenicicola.

Authors:  Devarshi U Gajjar; Anuradha K Pal; Trilok J Parmar; Anshul I Arora; Darshini A Ganatra; Forum B Kayastha; Bharat K Ghodadra; Abhay R Vasavada
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

5.  Interventions and Outcomes in Patients with Infectious Pseudomonas scleritis: A 10-Year Perspective.

Authors:  Sumayya Ahmad; Michelle Lopez; Marwan Attala; Anat Galor; Natalie A Stanciu; Darlene Miller; Leejee Suh; Thomas Albini; Victor L Perez; Carol L Karp; Janet L Davis; Eduardo Alfonso; Richard K Forster; Guillermo Amescua
Journal:  Ocul Immunol Inflamm       Date:  2017-10-17       Impact factor: 3.070

6.  Management and outcome of microbial anterior scleritis.

Authors:  Matthew A Cunningham; Jamie K Alexander; Alice Y Matoba; Dan B Jones; Kirk R Wilhemus
Journal:  Cornea       Date:  2011-09       Impact factor: 2.651

7.  Infectious scleritis mimicking severe ocular inflammation: atypical initial presentation.

Authors:  Somasheila I Murthy; Alok Sati; Virender Sangwan
Journal:  BMJ Case Rep       Date:  2013-02-20

8.  Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population.

Authors:  Seong Joon Ahn; Joo Youn Oh; Mee Kum Kim; Jin Hak Lee; Won Ryang Wee
Journal:  Korean J Ophthalmol       Date:  2010-11-23

Review 9.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Mitomycin: clinical applications in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.